SMMT
SMMT
NASDAQ · Biotechnology

Summit Therapeutics Inc

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$15.54
-0.06 (-0.38%)
Analyst Consensus
Strong Buy
23
Analysts
High
Coverage
Buy 18 78%
Hold 4 17%
Sell 1 4%
Price Target
Analyst Price Target +1,161.8% upside
Low Target $141.53
Average Target $196.08
High Target $244.39
Current Price $15.54
Current
$15.54
Target
$196.08
$141.53 $196.08 avg $244.39
Scenario Analysis
Bear Case
$141.53
810.7%
Low target
Base Case
$196.08
+1,161.8%
Avg target
Bull Case
$244.39
+1,472.7%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$36.91
-57.9% from high
52-Week Low
$13.83
+12.4% from low
50-Day SMA
$16.75
-7.2% vs SMA
200-Day SMA
$20.83
-25.4% vs SMA
RSI (14)
54.0
Neutral
Target vs 52W High
$196.08
+431.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 69% $257.58 +25.5%
AMGN
Amgen Inc
 Hold 42 50% $190.87 -45.2%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.6%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -2.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -89.6%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 78% $102.31 -66.8%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 +3.1%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -26.5%